CompanyADXNNasdaqGeneva, V8

Addex Therapeutics Ltd.

Addex Therapeutics develops small molecule allosteric modulators for neurological disorders.

6-KSep 28Latest SEC filing

Aug 26Latest story

August 2026

June 2026

Jun 30Regulatory decisionAddex Therapeutics Ltd.